Sulfadoxine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01299 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 24 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gout | KG + DL |
| 2 | bronchitis | KG + DL |
| 3 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 4 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 5 | diabetic nephropathy | KG + DL |
| 6 | conjunctivitis | KG + DL |
| 7 | appendicitis | KG + DL |
| 8 | obsolete hyperuricemia (disease) | KG + DL |
| 9 | Lesch-Nyhan syndrome | KG + DL |
| 10 | peritonitis | KG + DL |
| 11 | congestive heart failure | KG + DL |
| 12 | ulcerative colitis (disease) | KG + DL |
| 13 | chronic kidney disease | KG + DL |
| 14 | epiglottitis | KG + DL |
| 15 | fetal erythroblastosis | KG + DL |
| 16 | acute pulmonary heart disease | KG + DL |
| 17 | end stage renal failure | KG + DL |
| 18 | acute liver failure | KG + DL |
| 19 | hypouricemia, renal | KG + DL |
| 20 | urinary tract infection (disease) | KG + DL |
| 21 | congenital hypotrichosis with juvenile macular dystrophy | KG + DL |
| 22 | rheumatoid arthritis | KG + DL |
| 23 | cholecystolithiasis | KG + DL |
| 24 | osteoarthritis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.